Jichuan Pharmaceutical Co., Ltd. (600566.SH): Cao Fei's tender offer expires, stock will be suspended on July 18th.

China Finance APP News, Jichuan Pharmaceutical (600566.SH) announced that on June 16, 2025, the company disclosed the "Tender Offer Report of Hubei Jichuan Pharmaceutical Co., Ltd.". Mr. Cao Fei issued a comprehensive tender offer to all shareholders of Jichuan Pharmaceutical who hold unrestricted saleable shares, excluding Mr. Cao Longxiang, Jiangsu Jichuan Holding Group Co., Ltd., and Tibet Jichuan Enterprise Management Co., Ltd. The number of shares to be tendered in this tender offer is 351 million shares, accounting for 38.06% of the total share capital of the company. The tender offer price is 24.85 yuan/share (adjusted from 26.93 yuan/share due to the completion of the company's 2024 annual profit distribution plan). The tender offer period is from June 18, 2025 to July 17, 2025.